Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0000899243-21-032755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-12 | 2021-08-10 | FULC | Moxham Christopher | CSO | S - Sale+OE | $17.60 | -51.8K | 0 | -100% | -$911.4K |
| DM | 2021-08-12 | 2021-08-10 | FULC | Moxham Christopher | CSO | M - OptEx | $7.84 | +51.8K | 20.7K | New | +$406.0K |
| DM | 2021-08-12 | 2021-08-10 | FULC | Moxham Christopher | CSO | M - OptEx | $0.00 | -51.8K | 103.6K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stockm | 2021-08-10 | S | D | 31,071 | $18.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | M | A | 31,071 | $7.84 | 31,071 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-10 | S | D | 20,714 | $17.00 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-10 | M | A | 20,714 | $7.84 | 20,714 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2021-08-10 | M | D | 31,071 | $0.00 | 72,501 | D | $7.84 · — to 2029-01-21 | 31,071 Common Stock | (F3) The shares underlying the option are scheduled to vest 25% on the first anniversary of the vesting commencement date of January 22, 2020. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service. |
| 6 | Derivative | Stock Option (right to buy) | 2021-08-10 | M | D | 20,714 | $0.00 | 103,572 | D | $7.84 · — to 2029-01-21 | 20,714 Common Stock | (F3) The shares underlying the option are scheduled to vest 25% on the first anniversary of the vesting commencement date of January 22, 2020. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service. |